Exagen inc. to participate in upcoming investor conferences

Carlsbad, calif., feb. 04, 2025 (globe newswire) -- exagen inc. (nasdaq: xgn), a leading provider of autoimmune testing, today announced that management will participate in the following upcoming investor conferences:

XGN Ratings Summary

XGN Quant Ranking